Haddadin Yezan Munther
- SEC CIK
- 0001718004
In the past year, 2 open-market purchase filings worth $39.0K and no sales.
Current role at each company
- OTLK Outlook Therapeutics, Inc.Directoras of Jun 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $39.0K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$39.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Haddadin Yezan Munther as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 (view filing) | Jun 2 | 1 day | Haddadin Yezan MuntherDirector | PPurchase | +29.0K | $0.83 | +$24.1K | +78.0%66.2K after | |
| May 27, 2026 (view filing)3:24 PM ET | May 26 | 1 day | Haddadin Yezan MuntherDirector | PPurchase | +34.0K | $0.44 | +$15.0K | +1,073.6%37.2K after | |
| Mar 29, 2024 (view filing) | Mar 28 | 1 day | Haddadin Yezan MuntherDirector | PPurchase | +1.88K | $11.82 | +$22.2K | +59.4%5.05K after | |
| Oct 11, 2022 (view filing) | Oct 6-7 | 5 days | Haddadin Yezan MuntherDirector | PPurchase | +33.3K | $1.29 | +$42.9K | +111.1%63.3K after | 2 lots |
| Dec 2, 2021 (view filing) | Dec 2 | Same day | Haddadin Yezan MuntherDirector | PPurchase | +10.0K | $1.39 | +$13.9K | +50.0%30.0K after |